Experiencia con el uso de dalbavancina en la infección profunda de pie diabético
- 1 June 2022
- journal article
- research article
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 40 (6) , 296-301
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011)Diagnostic Microbiology and Infectious Disease, 2013
- Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomesJournal of Clinical Epidemiology, 2012
- 2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot InfectionsaClinical Infectious Diseases, 2012
- Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentationDiabetic Medicine, 2011
- Diagnosing diabetic foot osteomyelitis: is the combination of probe‐to‐bone test and plain radiography sufficient for high‐risk inpatients?Diabetic Medicine, 2011
- Emergence of multidrug-resistant Corynebacterium striatum as a nosocomial pathogen in long-term hospitalized patients with underlying diseasesDiagnostic Microbiology and Infectious Disease, 2006
- A review of the microbiology, antibiotic usage and resistance in chronic skin woundsJournal of Antimicrobial Chemotherapy, 2005
- Clinical significance of Corynebacterium striatum isolated from human samplesClinical Microbiology and Infection, 1997
- Probing to Bone in Infected Pedal UlcersJAMA, 1995
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994